FindTrial
Sign In

Polish Registry of Takotsubo Syndrome

Polish Registry of Takotsubo Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04634487
Acronym
Pol-Tako
Enrollment
1000
Registered
2020-11-18
Start date
2020-10-01
Completion date
2030-01-31
Last updated
2020-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Takotsubo Syndrome

Brief summary

Polish registry of takotsubo syndrome

Interventions

OTHERNo intervention

No intervention

Sponsors

Medical University of Warsaw
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

all patients with takotsubo syndrome

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with in-hospital complications and mortalitythrough study completion, an average of 1 yearIn hospital complications include atrial fibrillation, ventricular tachycardia, ventricular fibrillation, atrioventricular block, cardiogenic shock, cardiac arrest

Secondary

MeasureTime frameDescription
Number of participants with complications with echocardiographythrough study completion, an average of 1 yearComplications include: severe mitral regurgitation, fluid in the pericardium, right ventricle disfunction, ventricular septum rupture

Countries

Poland

Contacts

Primary ContactMonika Budnik, PhD
mbudnik@wum.edu.pl+48225991958

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026